免疫性血小板缺血和怀孕:诊断和管理中的挑战和机遇
Marina Beltrami-Moreira1, Amy Sharma2, James B Bussel3
1Department of Medicine, Division of Hematology, The Ohio State University Wexner Medical Center, The Ohio State University College of Medicine, Columbus, OH, USA.
Expert review of hematology
|August 6, 2024
概括
怀孕期间的免疫性血小板缺血 (ITP) 存在诊断和治疗方面的挑战. 目前的审查涵盖ITP管理,结果和新型治疗方法,如TPO-RAs,为临床医生提供见解.
科学领域:
- 血液学 血液学 血液学
- 产科 产科 产科 产科 产科
- 免疫学 免疫学 免疫学
背景情况:
- 怀孕期间免疫性血小板缺血 (ITP) 带来了重大的诊断和治疗挑战.
- 了解 ITP 和怀孕之间的相互作用对于最佳的患者和胎儿结果至关重要.
研究的目的:
- 审查当前的诊断标准和怀孕期间ITP的实验室实用性.
- 讨论ITP对怀孕结果的影响,反之亦然.
- 概述耐火性ITP和新生儿病例的治疗策略.
主要方法:
- 在PubMed.com上使用术语"免疫性血小板缺血"和"怀孕"进行了全面的文献搜索.
- 包括到2023年12月31日发表的相关文献.
- 对诊断,预后和治疗方法的审查.
主要成果:
- 血小板产量减少,可能受到胎盘激素的影响,可能会加剧与怀孕相关的ITP.
- 静脉注射免疫球蛋白 (IVIG) 和普得尼松是常见的第一线治疗方法,但可能需要二线药物.
- 血栓形成素受体激动剂 (TPO-RAs) 在耐火病例中表现有前途,尽管需要进一步研究VTE风险.
结论:
- 在怀孕期间治疗ITP需要仔细考虑诊断标准,治疗疗效和安全性.
- 新出现的证据支持用于耐火ITP的TPO-RA,需要进行持续的风险效益评估.
- 新生儿ITP管理和母乳养考虑是护理的重要方面.
相关概念视频
Disorders of Hemostasis
768
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
768
Development of Immunocompetence
296
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
296
Anticoagulant Drugs: Low-Molecular-Weight Heparins
657
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
657
Blood Transfusion and Agglutination
10.8K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.8K
Transcytosis of IgG
2.7K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
2.7K
Tumor Immunotherapy
497
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
497


